by The global biopharmaceutical market size is forecasted to reach from US$ 297.19 billion in 2021 to US$ 856.1 billion by 2030 and is anticipated to grow at compounded annual growth rate (CAGR) of 12.5% from 2021 to 2030, as per reports by market research and consulting organization Precedence Research.
The report contains 150+ pages with detailed analysis. The base year for the study has been considered 2021, the historic year 2017 and 2020, the forecast period considered is from 2021 to 2030. The biopharmaceutical market is analyzed on the basis of value (US$ Million), volume (Unit), and price (US$/Unit).
Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1422
The rising prevalence of various chronic diseases, growing geriatric population, rising investments in the research and development of the new drugs, supportive regulations of the government, and rising adoption of the biopharmaceuticals among the global population are some of the important factors that drives the growth of the global biopharmaceutical market.
The biopharmaceutical market is growing at a rapid rate and it accounts for around 20% of the global pharmaceutical industry. The increasing awareness about the effectiveness and availability of the biopharmaceuticals among the population is significantly boosting the demand for the biopharmaceuticals across the globe.
Scope of the Biopharmaceutical Market Report
| Report Coverage | Details |
| Market Size in 2021 | USD 297.19 Billion |
| Growth Rate | CAGR of 12.5% From 2021 to 2030 |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Type, Application, Region |
Competitive Landscape Analysis:
Some of the leading companies operating in the biopharmaceutical market are profiled in the market study. The report also underscores winning strategies adopted over the last few years and gauges impact of the same on growth trajectory exhibited by the market over the last few years.
Major companies operating in this report are
- Abbott Laboratories
- Amgen, Inc.
- Biogen, Inc.
- Eli Lilly and Company
- F. Hoffmann-La Roche, Ltd.
- Johnson & Johnson
- Merck & Co., Inc.
- Novo Nordisk A/S
- Pfizer, Inc.
- Sanofi
Market Dynamics
Driver
Rising demand for the low side-effect treatment
Traditionally, the treatment of the various chronic diseases were risky and resulted in adverse side-effects. For instance, the conventional chemotherapy was toxic and has high side-effects. The development of the improved biopharmaceuticals provided a safer alternative to such traditional therapeutics and increasing awareness regarding the benefits of the biopharmaceuticals over the traditional therapeutics is expected to drive the market growth.
Restraints
High cost of medicines and lack of adequate healthcare infrastructure
The high costs of the innovative biopharmaceuticals is restricting its adoption among the people in the low and middle income countries due to the low affordability. Moreover, the lack of proper healthcare infrastructure results in under-treatment. This is major factor that may hinder the growth of the global biopharmaceutical market during the forecast period.
Opportunities
New product launches and adoption of developmental strategies
The biopharmaceutical industry is fragmented owing to the presence of numerous big players. It is a rapidly growing market and has higher threat of the new market entrants. The various developmental strategies such as new product launches, partnerships, collaborations, and join ventures may have a positive impact on the market. For instance, Takeda Pharmaceutical entered into a partnership with Frazier Healthcare to form a new biopharmaceutical company named HilleVax, in June 2021.
Challenges
Stringent regulations and high capital investment
The biopharmaceutical market is regulated by the stringent government norms and regulations. Furthermore, a high initial capital investment is required to establish a biopharmaceutical company. Moreover, further investments are involved in the research, development, clinical trials, and approval of the newly developed medicines. Hence, huge capital requirement and stringent government regulations are the major concern for the market players.
Report Highlights
- Based on the type, the monoclonal antibodies segment dominated the market in 2020. The increased efficacy of the monoclonal antibodies to specifically target the affected cell and treat that cell without harming the normal cells results in the low or minimal side-effects. This is a major factor that has propelled the demand for the monoclonal antibodies for the treatment of various chronic diseases like cancer.
- Based on the application, the oncology segment dominated the global biopharmaceutical market in 2020. This is attributable to the increased adoption of the biopharmaceuticals in the treatment of various cancer like breast cancer, lungs cancer, and prostate cancer. The increased prevalence of cancer among the population is boosting the market growth.According to the International Agency for Research on Cancer, in the year 2020, around 19.3 million new cases of cancer were diagnosed and this number is expected to grow by 47% from 2020 to 2040.
Regional Snapshot
North America dominated the global biopharmaceutical market in 2020. The increased prevalence of various chronic diseases in the US and growing geriatric population has fueled the demand for the biopharmaceuticals. As per the American Cancer Society, around 1.8 million new cancer cases were reported in US in 2020. Moreover, the FDA plays a crucial role in the market growth of the biopharmaceutical market. The FDA approved 53 new novel drugs in 2020. The increased investments by the market players in the research and development of the new drugs and their clinical trials is expected to provide lucrative growth opportunities to the market players. Moreover, the increased government investments to develop the biopharmaceutical industry in US has significant contributions in the development of the North American market. US holds the property rights of the majority of the new drugs developed recently. North America is projected to stay dominant throughout the forecast period.
Asia Pacific is estimated to be the most opportunistic market during the forecast period. The countries like China, India, and South Korea are increasing their efforts in the development of the biopharmaceutical industry and attracting FDIs owing to the presence of cheap factors of production. The presence of few world’s top contract manufacturing organizations in Asia Pacific has significantly driven the growth of the biopharmaceutical market. Further rising prevalence of various chronic diseases and growing geriatric population in the region is presenting growth avenues to the market players. According to the WHO, 80% of the global geriatric population is expected to be living in the low and middle income countries. Furthermore, the rising awareness among the population regarding the biopharmaceuticals is expected to foster the demand for the biopharmaceuticals in the region in the forthcoming years.
Market Segmentation
By Type
- Monoclonal Antibodies
- Insulin
- Vaccine
- Hormone
- Interferon
- Erythropoietin
- Growth & Coagulation Factor
- Others
By Application
- Blood Disorder
- Oncology
- Infectious Disease
- Neurological Disease
- Cardiovascular Disease
- Metabolic Disease
- Immunology
- Others
Regional Segmentation
– North America (U.S. and Canada)
– Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
– Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
– Latin America (Brazil and Rest of Latin America)
– Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Why should you invest in this report?
If you are aiming to enter the global biopharmaceutical market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for biopharmaceutical are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030, so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1422
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Biopharmaceutical Market
5.1. COVID-19 Landscape: Biopharmaceutical Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Biopharmaceutical Market, By Type
8.1. Biopharmaceutical Market, by Type, 2021-2030
8.1.1. Monoclonal Antibodies
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Insulin
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Vaccine
8.1.3.1. Market Revenue and Forecast (2019-2030)
8.1.4. Hormone
8.1.4.1. Market Revenue and Forecast (2019-2030)
8.1.5. Interferon
8.1.5.1. Market Revenue and Forecast (2019-2030)
8.1.6. Erythropoietin
8.1.6.1. Market Revenue and Forecast (2019-2030)
8.1.7. Growth & Coagulation Factor
8.1.7.1. Market Revenue and Forecast (2019-2030)
8.1.8. Others
8.1.8.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Biopharmaceutical Market, By Application
9.1. Biopharmaceutical Market, by Application, 2021-2030
9.1.1. Blood Disorder
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Oncology
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Infectious Disease
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Neurological Disease
9.1.4.1. Market Revenue and Forecast (2019-2030)
9.1.5. Cardiovascular Disease
9.1.5.1. Market Revenue and Forecast (2019-2030)
9.1.6. Metabolic Disease
9.1.6.1. Market Revenue and Forecast (2019-2030)
9.1.7. Immunology
9.1.7.1. Market Revenue and Forecast (2019-2030)
9.1.8. Others
9.1.8.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Biopharmaceutical Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Type (2019-2030)
10.1.2. Market Revenue and Forecast, by Application (2019-2030)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Type (2019-2030)
10.1.3.2. Market Revenue and Forecast, by Application (2019-2030)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Type (2019-2030)
10.1.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Type (2019-2030)
10.2.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Type (2019-2030)
10.2.3.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Type (2019-2030)
10.2.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Type (2019-2030)
10.2.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Type (2019-2030)
10.2.6.2. Market Revenue and Forecast, by Application (2019-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Type (2019-2030)
10.3.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Type (2019-2030)
10.3.3.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Type (2019-2030)
10.3.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Type (2019-2030)
10.3.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Type (2019-2030)
10.3.6.2. Market Revenue and Forecast, by Application (2019-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Type (2019-2030)
10.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Type (2019-2030)
10.4.3.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Type (2019-2030)
10.4.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Type (2019-2030)
10.4.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Type (2019-2030)
10.4.6.2. Market Revenue and Forecast, by Application (2019-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Type (2019-2030)
10.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Type (2019-2030)
10.5.3.2. Market Revenue and Forecast, by Application (2019-2030)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Type (2019-2030)
10.5.4.2. Market Revenue and Forecast, by Application (2019-2030)
Chapter 11. Company Profiles
11.1. Abbott Laboratories
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Amgen, Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Biogen, Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Eli Lilly and Company
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. F. Hoffmann-La Roche, Ltd.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Johnson & Johnson
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Merck & Co., Inc.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Novo Nordisk A/S
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Pfizer, Inc.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Sanofi
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Purchase Full Research Report @ https://www.precedenceresearch.com/checkout/1422
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Read Also:
- Cancer Drugs Market Predicted to Reach US$ 272 Bn by 2030 – Potential Opportunity is Opening in the Coming Year (2021-2030)
- Laboratory Supplies Market Size is Forecasted to Reach US$ 53.6 billion by 2030
- Factoring Services Market Size Analysis, Top Manufacturers Strategy by Industry Sales, Emerging Demands, Trends Analysis, Business Opportunity, Growth Strategy and Global Forecast 2021-2030
- Automotive Telematics Market By Economic Growth Factors, Development Status, Industry Overview, Future Plans, Competitive Landscape and Opportunities Forecast 2030
- Vacation Rental Market 2021 Newest Industry Data, Growth Prospects, Future Trends And Forecast to 2030
- Automotive Human Machine Interface (HMI) Market 2021 Newest Industry Data, Growth Prospects, Future Trends And Forecast 2030
- Energy Efficient Lighting Technology Market Size is Forecasted to Reach US$ 406.44 billion by 2030
